Biomarkers and outcomes: the example of traumatic brain injury -- Biomarkers in neurological injury: fibrinogen and beyond -- Biomarkers for liver injury: micro RNAS and beyond -- Biomarkers in muscle injury: proteomic and beyond -- Biomarkers in lung injury: -- Biomarkers and penetrating thoracic trauma -- Biomarkers in renal injury -- Biomarkers of heart muscle damage and injury: mRNA expression and beyond -- Biomarkers of burn severity -- Biomarkers and prognosis in sepsis: muscle mass and beyond -- Biomarkers of acute inflammation in polytrauma -- Electrolytes in critical care as a biomarker -- Critical care and 5'-Aminolevulinate synthase 2 (ALAS2) expression as a biomarker -- miRNAs as biomarkers of critically Ill patients -- C-Reactive protein and implications to the Neonatal Intensive Care Unit -- 129Xe magnetic resonance imaging (MRI) as a biomarker and implications for critical care -- Gas imaging of aeration and fractional ventilation as a biomarker in critical care -- Circulating PD-1/2B4 CD8+ T-cells patterns as biomarkers and the ICU -- Collagen and fibrotic biomarkers in critical care -- Biomarker mortality prediction model for sepsis in critical care: parsimonious modelling and beyond -- Acute kidney injury in critical care and biomarkers -- Platelet Function Assays in trauma -- Coagulation tests and fibrinogen concentrate in trauma -- Biomarkers and the time window-in trauma patients -- Inflammatory biomarkers in animal model of brain Injury. .